Designation supported by promising safety and efficacy data from Phase 1/2 study in heavily pretreated patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic ...
College Station is a place people want to visit, stay, and come back to again and again,” Rep. Trey Wharton said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback